By Professor Nadine Ezard

Preprints

Bonevski B; Jackson M; Austin E; Lintzeris N; Ezard N; Gartner C; Oldmeadow C; Haber P; Hallinan R; Rodgers C; Ho T; Nean M; Harrod M; Dunlop A, 2024, HARMONY (HARM reduction for Opiates, Nicotine and You) Trial: Protocol of a Randomised Controlled Trial of the Effectiveness of Vaporised Nicotine Products for Tobacco Smoking Cessation amongst NSW Opiate Agonist Treatment Clients, http://dx.doi.org/10.1101/2024.06.21.24309014

Oldmeadow C; Nolan E; Bonevski B; Jackson M; Lintzeris N; Ezard N; Gartner C; Haber P; Hallinan R; Rodgers C; Ho T; Dunlop A, 2024, HARMONY (HARM reduction for Opiates, Nicotine and You): Statistical Analysis Plan for a Randomised Controlled Trial of the Effectiveness of Vaporised Nicotine Products for Tobacco Smoking Cessation amongst NSW Opiate Agonist Treatment Clients, http://dx.doi.org/10.1101/2024.06.21.24309282

Sivak L; Reilly R; Crumpen S; Treloar C; McKetin R; Butt J; Roe Y; Ezard N; Quinn B; Nagle J; Longbottom W; Warrior C; Ward J, 2024, An acceptability and feasibility study of the We Can Do This web-app in Australian primary care and residential rehabilitation settings for Aboriginal and Torres Strait Islander people who use methamphetamine (Preprint), http://dx.doi.org/10.2196/preprints.58369

Reilly R; McKetin R; Barzi F; Degan T; Ezard N; Conigrave K; Butt J; Roe Y; Wand H; Quinn B; Longbottom W; Treloar C; Dunlop A; Ward J, 2024, We Can Do This: A web-based therapeutic program for reducing methamphetamine use -amongst Aboriginal and Torres Strait Islander people: Findings from a wait-list control, randomised trial (Preprint), http://dx.doi.org/10.2196/preprints.58341

Siefried KJ; Bascombe F; Clifford B; Liu Z; Middleton P; Kay-Lambkin F; Freestone J; Herman D; Millard M; Steele M; Acheson L; Moller C; Bath N; Ezard N, 2023, Effect of a Smartphone App (S-Check) on Actual and Intended Help-Seeking and Motivation to Change Methamphetamine Use Among Adult Consumers of Methamphetamine in Australia: Randomized Waitlist-Controlled Trial (Preprint), http://dx.doi.org/10.2196/preprints.55663

Clifford B; Van Gordon K; Magee F; Malone V; Siefried K; Graham D; Ezard N, 2022, “There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia, http://dx.doi.org/10.1101/2022.08.01.22278295

Bonevski B; Rich JL; Skelton E; Garfield J; Baker AL; Segan C; Gartner C; Walker N; Borland R; Daglish M; Dunlop A; Oldmeadow C; Bauld L; Bullen C; Ezard N; McCrohan R; Jacka D; White S; Lubman DI; Manning V, 2022, NEAT (NicotinE As Treatment) Trial: Protocol of a randomised controlled trial of vaporised nicotine products compared with nicotine replacement therapy following discharge from residential withdrawal services, http://dx.doi.org/10.1101/2022.05.15.22275118

Jong CD; Farhoudian A; Vahidi M; Ebrahimi M; Ekhtiari H; Rafei P; Busse A; Brady K; Yunesian M; Ezard N; Radfar R; Baldacchino A, 2020, Substance use Treatment and Harm Reduction Services for Migrants and Refugees in the COVID-19 Pandemic: Findings from a Global Survey, http://dx.doi.org/10.21203/rs.3.rs-123740/v1

Ezard N; Clifford B; Dunlop A; Bruno R; Carr A; Liu Z; Siefried K; Lintzeris N, 2020, Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study, http://dx.doi.org/10.21203/rs.3.rs-30957/v1

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Quinn B; Treloar C; Gray D; Dunlop A; Wilkes E; Ward J, 2019, ‘We Can Do This’: a web-based therapeutic program for reducing methamphetamine use and increasing help-seeking amongst Aboriginal and Torres Strait Islander people: Wait-list control, randomised trial protocol (Preprint), http://dx.doi.org/10.2196/preprints.14084

Back to profile page